Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > ALL revised Analyst predictions average $63/share on CXR!
View:
Post by TechTarget on Oct 27, 2015 8:59am

ALL revised Analyst predictions average $63/share on CXR!

TD Securities currently have a $60.00 price objective. was at $105.00 when it was trading near $120 less than two months ago!  They rate CXR as a BUY

RBC Capital revised target price on Concordia Healthcare to $77.00 and“outperform”

Scotiabank  has “sector outperform” rating with $75.00 target price from $80.00 when the stock was trading at over $115 eight weeks agao.

S&P Equity Research restated a “buy” rating and set a $60.00 price objective

Canaccord Genuity reaffirmed a “buy” rating and set a $55.00 target price on shares of Concordia Healthcare.

The stock presently has an average rating of “Buy” and a consensus target price of $62.94.  These are all post crash ratings!
 
Comment by visionaryfool on Oct 27, 2015 9:02am
Is this US or CAD?
Comment by humbledude on Oct 27, 2015 9:18am
on the report, CXR is CAD TSX.   CXRX is USD Nasdaq. 
Concordia Healthcare Corp.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities